Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

The new method showed that endometriotic tissue has lower estrogen receptor levels but similar progesterone levels compared to normal endometrium, with both following a similar cycle.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.